Suppr超能文献

结直肠腹腔镜手术中个体化与传统气腹压力策略:一项多中心随机临床研究的原理与研究方案

An individualised versus a conventional pneumoperitoneum pressure strategy during colorectal laparoscopic surgery: rationale and study protocol for a multicentre randomised clinical study.

作者信息

Diaz-Cambronero O, Mazzinari G, Errando C L, Schultz M J, Flor Lorente B, García-Gregorio N, Vila Montañés M, Robles-Hernández Daniel, Olmedilla Arnal L E, Martín-De-Pablos A, Marqués Marí A, Argente Navarro M P

机构信息

Department of Anaesthesiology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Perioperative Medicine Research Group, Instituto de Investigación Sanitaria La Fe (IIS laFe), Avinguda de Fernando Abril Martorell 106, 46026, Valencia, Spain.

出版信息

Trials. 2019 Apr 3;20(1):190. doi: 10.1186/s13063-019-3255-1.

Abstract

BACKGROUND

A recent study shows that a multifaceted strategy using an individualised intra-abdominal pressure titration strategy during colorectal laparoscopic surgery results in an acceptable workspace at low intra-abdominal pressure in most patients. The multifaceted strategy, focused on lower to individualised intra-abdominal pressures, includes prestretching the abdominal wall during initial insufflation, deep neuromuscular blockade, low tidal volume ventilation settings and a modified lithotomy position. The study presented here tests the hypothesis that this strategy improves outcomes of patients scheduled for colorectal laparoscopic surgery.

METHODS

The Individualized Pneumoperitoneum Pressure in Colorectal Laparoscopic Surgery versus Standard Therapy (IPPCollapse-II) study is a multicentre, two-arm, parallel-group, single-blinded randomised 1:1 clinical study that runs in four academic hospitals in Spain. Patients scheduled for colorectal laparoscopic surgery with American Society of Anesthesiologists classification I to III who are aged > 18 years and are without cognitive deficits are randomised to an individualised pneumoperitoneum pressure strategy (the intervention group) or to a conventional pneumoperitoneum pressure strategy (the control group). The primary outcome is recovery assessed with the Post-operative Quality of Recovery Scale (PQRS) at postoperative day 1. Secondary outcomes include PQRS score in the post anaesthesia care unit and at postoperative day 3, postoperative complications until postoperative day 28, hospital length of stay and process-related outcomes.

DISCUSSION

The IPPCollapse-II study will be the first randomised clinical study that assesses the impact of an individualised pneumoperitoneum pressure strategy focused on working with the lowest intra-abdominal pressure during colorectal laparoscopic surgery on relevant patient-centred outcomes. The results of this large study, to be disseminated through conference presentations and publications in international peer-reviewed journals, are of ultimate importance for optimising the care and safety of laparoscopic abdominal surgery. Selection of patient-reported outcomes as the primary outcome of this study facilitates the translation into clinical practice. Access to source data will be made available through anonymised datasets upon request and after agreement of the Steering Committee of the IPPCollapse-II study.

TRIAL REGISTRATION

ClinicalTrials.gov, NCT02773173 . Registered on 16 May 2016. EudraCT, 2016-001693-15. Registered on 8 August 2016.

摘要

背景

最近一项研究表明,在结直肠腹腔镜手术期间采用多方面策略,即个体化腹内压滴定策略,可使大多数患者在低腹内压下获得可接受的手术操作空间。该多方面策略侧重于降低至个体化腹内压,包括在初始充气时预拉伸腹壁、深度神经肌肉阻滞、低潮气量通气设置和改良截石位。本文介绍的这项研究检验了这样一个假设,即该策略可改善计划接受结直肠腹腔镜手术患者的预后。

方法

结直肠腹腔镜手术个体化气腹压力与标准治疗(IPPCollapse-II)研究是一项多中心、双臂、平行组、单盲随机1:1临床研究,在西班牙的四家学术医院开展。计划接受结直肠腹腔镜手术、美国麻醉医师协会分级为I至III级、年龄大于18岁且无认知缺陷的患者被随机分为个体化气腹压力策略组(干预组)或传统气腹压力策略组(对照组)。主要结局是术后第1天使用术后恢复质量量表(PQRS)评估的恢复情况。次要结局包括麻醉后护理单元和术后第3天的PQRS评分、术后至术后第28天的并发症、住院时间以及与手术过程相关的结局。

讨论

IPPCollapse-II研究将是第一项评估在结直肠腹腔镜手术期间以最低腹内压进行个体化气腹压力策略对以患者为中心的相关结局影响的随机临床研究。这项大型研究的结果将通过会议报告和在国际同行评审期刊上发表进行传播,对于优化腹腔镜腹部手术的护理和安全性至关重要。选择患者报告的结局作为本研究的主要结局有助于将其转化为临床实践。在IPPCollapse-II研究指导委员会同意并应要求后,将通过匿名数据集提供源数据访问权限。

试验注册

ClinicalTrials.gov,NCT02773173。于2016年5月16日注册。EudraCT,2016-001693-15。于2016年8月8日注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89f6/6446296/b2082bf11776/13063_2019_3255_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验